Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 1997

View Archived Issues

Company Profile: PharmaPrint

Geron: Q3 1997 highlights

Integra LifeSciences: Q3 1997 highlights

Acacia Biosciences receives SBIR grant for drug discovery research

Maxim reports promising data from AML trial with Maxamine

Miravant reports promising interim phase III results for breast cancer trial

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Ligand: Q3 1997 highlights

Antiviral thiazolidines and thiazolidinones from INSERM

Diagnostic use of specific sigma2 ligands described by Wake Forest University

MDR modulators prepared at Janssen

Bayer develops CETP inhibitors

Vitronectin receptor antagonists described by Hoechst

Method of inactivating RNA viruses offered for licensing

Actinomycin D: new use in AIDS therapy available for licensing

New inhibitor of inflammatory bone resorption presented at Tokyo congress

New glucocorticoid from Kissei under development for asthma

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Results of IDEC-151/SB-217969 phase I trial reported

NeoTherapeutics' cognition enhancer in preclinical testing

Plant-derived biflavonoid with antiinflammatory activity

Active principle of herbal medicine with immunomodulating effects

Abecarnil reverses benzodiazepine resistance in mice

Plant extract with both antiinflammatory and antihistaminic activity

New mechanism involved in the anxiolytic effect of flesinoxan?

Sanofi in-licenses antidiabetic drug from Bayer

Fareston launched in U.S. for metastatic breast cancer

Profile of an mGluR2/mGluR3 agonist

New antipsychotic reported in development at Merck KGaA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...